Annual report pursuant to Section 13 and 15(d)

Financial Instruments (Tables)

v3.20.4
Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2020
Investments All Other Investments [Abstract]  
Schedule of Cash and Cash Equivalents As of December 31, 2020, the Company’s cash and cash equivalents were as follows:

 

 

 

 

 

 

 

Gross

 

 

 

 

 

 

Cash and

 

 

 

 

 

 

 

 

 

 

 

Unrealized

 

 

Fair

 

 

Cash

 

 

Marketable

 

 

 

Cost

 

 

Losses

 

 

Value

 

 

Equivalents

 

 

Securities

 

Cash

 

$

44,795

 

 

$

 

 

$

44,795

 

 

$

44,795

 

 

$

 

Level 1:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

 

70,022

 

 

 

 

 

 

70,022

 

 

 

70,022

 

 

 

 

Total

 

$

114,817

 

 

$

 

 

$

114,817

 

 

$

114,817

 

 

$

 

 

As of December 31, 2019, the Company’s cash and cash equivalents were as follows:

 

 

 

 

 

 

 

Gross

 

 

 

 

 

 

Cash and

 

 

 

 

 

 

 

 

 

 

 

Unrealized

 

 

Fair

 

 

Cash

 

 

Marketable

 

 

 

Cost

 

 

Losses

 

 

Value

 

 

Equivalents

 

 

Securities

 

Cash

 

$

23,710

 

 

$

 

 

$

23,710

 

 

$

23,710

 

 

$

 

Level 1:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

 

20,355

 

 

 

 

 

 

20,355

 

 

 

20,355

 

 

 

 

Total

 

$

44,065

 

 

$

 

 

$

44,065

 

 

$

44,065

 

 

$

 

 

Summary of Quantitative Information with Respect to Significant Unobservable Inputs

The following table summarizes quantitative information with respect to the significant unobservable inputs that were used to value the 2020 Stock Warrants:

 

 

Compensation

 

 

Performance

 

 

 

Warrant

 

 

Warrant

 

Volatility

 

 

88

%

 

 

85

%

Risk-free rate

 

 

0.23

%

 

 

0.34

%

Term

 

1.7 years

 

 

3.7 years